{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:27:55Z","timestamp":1789673275017,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T00:00:00Z","timestamp":1725580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.eimce.2024.07.001","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T19:53:12Z","timestamp":1722973992000},"page":"442-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-8001","authenticated-orcid":false,"given":"Mario","family":"Fern\u00e1ndez-Ruiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7477-2033","authenticated-orcid":false,"given":"Juan Jos\u00e9","family":"Cast\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5402-3334","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"del Pozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3209-2563","authenticated-orcid":false,"given":"Jordi","family":"Carratal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6959-5263","authenticated-orcid":false,"given":"Jes\u00fas","family":"Fort\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8571-2124","authenticated-orcid":false,"given":"Miguel","family":"Salavert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1529-6302","authenticated-orcid":false,"given":"Juli\u00e1n","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9520-8255","authenticated-orcid":false,"given":"Jos\u00e9 Mar\u00eda","family":"Aguado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fern\u00e1ndez Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bel\u00e9n","family":"Loeches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Tom\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Oltra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Resino-Foz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Garc\u00eda V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"M\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esperanza","family":"Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Braojos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"L\u00f3pez-Medrano P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Machuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Cobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"L\u00f3pez Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Reguera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Diego","family":"Ruiz Mesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Tiraboschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Abella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Masi\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"del Toro L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Dolores","family":"D\u00edaz L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Carrasco-Ant\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Merchante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regino","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Mata-Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente","family":"Abril","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0005","article-title":"Burden of hospitalizations related to pneumococcal infection in Spain (2016-2020)","volume":"12","author":"Gil-Prieto","year":"2023","journal-title":"Antibiotics (Basel)."},{"issue":"5","key":"10.1016\/j.eimce.2024.07.001_bib0010","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/14737167.2022.2020649","article-title":"All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain","volume":"22","author":"Rejas","year":"2022","journal-title":"Expert Rev Pharmacoecon Outcomes Res."},{"issue":"7","key":"10.1016\/j.eimce.2024.07.001_bib0015","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"issue":"12","key":"10.1016\/j.eimce.2024.07.001_bib0020","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.cmi.2022.06.021","article-title":"Effect of positive microbiological testing on antibiotic de-escalation and outcomes in community-acquired pneumonia: a propensity score analysis","volume":"28","author":"Abelenda-Alonso","year":"2022","journal-title":"Clin Microbiol Infect."},{"issue":"2","key":"10.1016\/j.eimce.2024.07.001_bib0025","article-title":"Antimicrobial stewardship techniques for critically ill patients with pneumonia","volume":"12","author":"Adams","year":"2023","journal-title":"Antibiotics (Basel)."},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cmi.2021.09.025","article-title":"Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis","volume":"28","author":"Gentilotti","year":"2022","journal-title":"Clin Microbiol Infect."},{"issue":"10","key":"10.1016\/j.eimce.2024.07.001_bib0035","article-title":"Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections","volume":"10","author":"Schuetz","year":"2017","journal-title":"Cochrane Database Syst Rev."},{"issue":"6","key":"10.1016\/j.eimce.2024.07.001_bib0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00134-023-07033-8","article-title":"ERS\/ESICM\/ESCMID\/ALAT guidelines for the management of severe community-acquired pneumonia","volume":"49","author":"Martin-Loeches","year":"2023","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/rmed.2000.0977","article-title":"The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures","volume":"95","author":"Waterer","year":"2001","journal-title":"Respir Med."},{"issue":"4","key":"10.1016\/j.eimce.2024.07.001_bib0050","first-page":"CR171","article-title":"Assessment of the usefulness of sputum Gram stain and culture for diagnosis of community-acquired pneumonia requiring hospitalization","volume":"14","author":"Miyashita","year":"2008","journal-title":"Med Sci Monit."},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciy024","article-title":"The clinical utility of methicillin-resistant Staphylococcus aureus (MRSA) nasal screening to rule out MRSA pneumonia: a diagnostic meta-analysis with antimicrobial stewardship implications","volume":"67","author":"Parente","year":"2018","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimce.2024.07.001_bib0060","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2147\/IDR.S321168","article-title":"Urinary antigen testing for respiratory infections: current perspectives on utility and limitations","volume":"15","author":"Kim","year":"2022","journal-title":"Infect Drug Resist."},{"issue":"Suppl 2","key":"10.1016\/j.eimce.2024.07.001_bib0065","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis."},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0070","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1186\/s13063-022-06467-7","article-title":"Impact of rapid molecular testing on diagnosis, treatment and management of community-acquired pneumonia in Norway: a pragmatic randomised controlled trial (CAPNOR)","volume":"23","author":"Serigstad","year":"2022","journal-title":"Trials."},{"issue":"10","key":"10.1016\/j.eimce.2024.07.001_bib0075","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1093\/cid\/ciaa508","article-title":"Molecular testing for acute respiratory tract infections: clinical and diagnostic recommendations from the IDSA\u2019s Diagnostics Committee","volume":"71","author":"Hanson","year":"2020","journal-title":"Clin Infect Dis."},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s13054-020-03091-2","article-title":"Update of the treatment of nosocomial pneumonia in the ICU","volume":"24","author":"Zaragoza","year":"2020","journal-title":"Crit Care."},{"key":"10.1016\/j.eimce.2024.07.001_bib0085","unstructured":"Grupo de Trabajo de Enfermedades Infecciosas y Sepsis de la Sociedad Espa\u00f1ola de Medicina Intensiva Cr\u00edtica y Unidades Coronarias (SEMICyUC). Estudio Nacional de Vigilancia de Infecci\u00f3n Nosocomial en Servicios de Medicina Intensiva (ENVIN-HELICS), Informe 2023. Available from: https:\/\/hws.vhebron.net\/envin-helics\/Help\/Informe%20ENVIN-UCI%202023.pdf (\u00faltimo acceso: 30 de Abril de 2024)."},{"issue":"2","key":"10.1016\/j.eimce.2024.07.001_bib0090","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-0041-1740981","article-title":"Viral ventilator-associated pneumonia\/hospital-acquired pneumonia","volume":"43","author":"Luyt","year":"2022","journal-title":"Semin Respir Crit Care Med."},{"issue":"5","key":"10.1016\/j.eimce.2024.07.001_bib0095","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.eimce.2024.07.001_bib0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.diagmicrobio.2017.11.010","article-title":"Evaluation of the molecular Xpert Xpress Flu\/RSV assay vs. Alere i Influenza A & B assay for rapid detection of influenza viruses","volume":"90","author":"Chen","year":"2018","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"3","key":"10.1016\/j.eimce.2024.07.001_bib0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230183","article-title":"Multicenter evaluation of the QIAstat Respiratory Panel-A new rapid highly multiplexed PCR based assay for diagnosis of acute respiratory tract infections","volume":"15","author":"Parcina","year":"2020","journal-title":"PLoS One."},{"issue":"2","key":"10.1016\/j.eimce.2024.07.001_bib0110","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01658-17","article-title":"Multicenter evaluation of the ePlex respiratory pathogen panel for the detection of viral and bacterial respiratory tract pathogens in nasopharyngeal swabs","volume":"56","author":"Babady","year":"2018","journal-title":"J Clin Microbiol."},{"key":"10.1016\/j.eimce.2024.07.001_bib0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejro.2021.100350","article-title":"Role of high resolution computed tomography chest in the diagnosis and evaluation of COVID-19 patients: a systematic review and meta-analysis","volume":"8","author":"Ishfaq","year":"2021","journal-title":"Eur J Radiol Open."},{"issue":"3","key":"10.1016\/j.eimce.2024.07.001_bib0120","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MCP.0000000000000567","article-title":"Computed tomography scan contribution to the diagnosis of community-acquired pneumonia","volume":"25","author":"Garin","year":"2019","journal-title":"Curr Opin Pulm Med."},{"issue":"11","key":"10.1016\/j.eimce.2024.07.001_bib0125","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1007\/s00330-019-06235-3","article-title":"Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography","volume":"29","author":"Kunihiro","year":"2019","journal-title":"Eur Radiol."},{"issue":"2","key":"10.1016\/j.eimce.2024.07.001_bib0130","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.chest.2016.10.039","article-title":"Accuracy of lung ultrasonography in the diagnosis of pneumonia in adults: Systematic review and meta-analysis","volume":"151","author":"Llamas-Alvarez","year":"2017","journal-title":"Chest."},{"issue":"4","key":"10.1016\/j.eimce.2024.07.001_bib0135","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041402","article-title":"Infectious pneumonia and lung ultrasound: a review","volume":"12","author":"Boccatonda","year":"2023","journal-title":"J Clin Med."},{"issue":"6","key":"10.1016\/j.eimce.2024.07.001_bib0140","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1086\/377539","article-title":"High-dose, short-course levofloxacin for community-acquired pneumonia: a new treatment paradigm","volume":"37","author":"Dunbar","year":"2003","journal-title":"Clin Infect Dis."},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jac\/dkm119","article-title":"Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study","volume":"60","author":"File","year":"2007","journal-title":"J Antimicrob Chemother."},{"issue":"9","key":"10.1016\/j.eimce.2024.07.001_bib0150","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.21037\/jtd.2016.08.30","volume":"8","author":"Zhao","year":"2016","journal-title":"J Thorac Dis."},{"issue":"9","key":"10.1016\/j.eimce.2024.07.001_bib0155","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial","volume":"176","author":"Uranga","year":"2016","journal-title":"JAMA Intern Med."},{"issue":"10280","key":"10.1016\/j.eimce.2024.07.001_bib0160","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0140-6736(21)00313-5","article-title":"Discontinuing \u03b2-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial","volume":"397","author":"Dinh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.eimce.2024.07.001_bib0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.pupt.2017.06.008","article-title":"Individualizing duration of antibiotic therapy in community-acquired pneumonia","volume":"45","author":"Aliberti","year":"2017","journal-title":"Pulm Pharmacol Ther."},{"issue":"19","key":"10.1016\/j.eimce.2024.07.001_bib0170","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":"Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.annfar.2008.10.021","article-title":"Duration of antibiotic therapy for ventilator-associated pneumonia: comparison of 7 and 10 days. A pilot study","volume":"28","author":"Fekih Hassen","year":"2009","journal-title":"Ann Fr Anesth Reanim."},{"issue":"8","key":"10.1016\/j.eimce.2024.07.001_bib0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041290","article-title":"Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment","volume":"7","author":"Capellier","year":"2012","journal-title":"PLoS One."},{"issue":"6","key":"10.1016\/j.eimce.2024.07.001_bib0185","doi-asserted-by":"crossref","first-page":"R218","DOI":"10.1186\/cc11862","article-title":"A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia","volume":"16","author":"Kollef","year":"2012","journal-title":"Crit Care."},{"issue":"7","key":"10.1016\/j.eimce.2024.07.001_bib0190","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00134-022-06690-5","article-title":"Comparison of 8 versus 15 days of antibiotic therapy for Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized, controlled, open-label trial","volume":"48","author":"Bougl\u00e9","year":"2022","journal-title":"Intensive Care Med."},{"issue":"12","key":"10.1016\/j.eimce.2024.07.001_bib0195","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/j.1469-0691.2011.03542.x","article-title":"Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia--a propensity-adjusted analysis","volume":"17","author":"Choudhury","year":"2011","journal-title":"Clin Microbiol Infect."},{"issue":"6","key":"10.1016\/j.eimce.2024.07.001_bib0200","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1378\/chest.13-0076","article-title":"Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis","volume":"144","author":"Dimopoulos","year":"2013","journal-title":"Chest."},{"issue":"8","key":"10.1016\/j.eimce.2024.07.001_bib0205","article-title":"Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults","volume":"2015","author":"Pugh","year":"2015","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"10.1016\/j.eimce.2024.07.001_bib0210","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00582-2017","volume":"50","author":"Torres","year":"2017","journal-title":"Eur Respir J."},{"issue":"12","key":"10.1016\/j.eimce.2024.07.001_bib0215","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S1473-3099(19)30403-7","article-title":"Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial","volume":"19","author":"Kollef","year":"2019","journal-title":"Lancet Infect Dis."},{"issue":"4","key":"10.1016\/j.eimce.2024.07.001_bib0220","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/cid\/ciac809","article-title":"Less is more: a 7-day course of antibiotics is the evidence-based treatment for Pseudomonas aeruginosa ventilator-associated pneumonia","volume":"76","author":"Metersky","year":"2023","journal-title":"Clin Infect Dis."},{"issue":"4","key":"10.1016\/j.eimce.2024.07.001_bib0225","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1093\/cid\/ciac784","article-title":"Less is more? Antibiotic treatment duration in Pseudomonas aeruginosa ventilator-associated pneumonia","volume":"76","author":"Albin","year":"2023","journal-title":"Clin Infect Dis."},{"issue":"7","key":"10.1016\/j.eimce.2024.07.001_bib0230","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(16)00053-0","article-title":"Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial","volume":"16","author":"de Jong","year":"2016","journal-title":"Lancet Infect Dis."},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0235","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","article-title":"Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis","volume":"18","author":"Schuetz","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"10.1016\/j.eimce.2024.07.001_bib0240","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1080\/14787210.2021.1834848","article-title":"Role of the inflammatory response in community-acquired pneumonia: clinical implications","volume":"20","author":"Rombauts","year":"2022","journal-title":"Expert Rev Anti Infect Ther."},{"issue":"2","key":"10.1016\/j.eimce.2024.07.001_bib0245","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc10103","article-title":"Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial","volume":"15","author":"Fern\u00e1ndez-Serrano","year":"2011","journal-title":"Crit Care."},{"issue":"9977","key":"10.1016\/j.eimce.2024.07.001_bib0250","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(14)62447-8","article-title":"Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"385","author":"Blum","year":"2015","journal-title":"Lancet."},{"issue":"7","key":"10.1016\/j.eimce.2024.07.001_bib0255","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA."},{"issue":"8","key":"10.1016\/j.eimce.2024.07.001_bib0260","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1001\/jamainternmed.2019.1438","article-title":"Effectiveness of a bundled intervention including adjunctive corticosteroids on outcomes of hospitalized patients with community-acquired pneumonia: a stepped-wedge randomized clinical trial","volume":"179","author":"Lloyd","year":"2019","journal-title":"JAMA Intern Med."},{"issue":"2","key":"10.1016\/j.eimce.2024.07.001_bib0265","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02535-2020","article-title":"Adjunctive treatment with oral dexamethasone in non-ICU patients hospitalised with community-acquired pneumonia: a randomised clinical trial","volume":"58","author":"Wittermans","year":"2021","journal-title":"Eur Respir J."},{"issue":"8","key":"10.1016\/j.eimce.2024.07.001_bib0270","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia","volume":"48","author":"Meduri","year":"2022","journal-title":"Intensive Care Med."},{"issue":"21","key":"10.1016\/j.eimce.2024.07.001_bib0275","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med."},{"issue":"26","key":"10.1016\/j.eimce.2024.07.001_bib0280","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016239","article-title":"Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: a meta-analysis","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine (Baltimore)."},{"issue":"12","key":"10.1016\/j.eimce.2024.07.001_bib0285","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1093\/cid\/ciad496","article-title":"Efficacy and safety of corticosteroid therapy for community-acquired pneumonia: a meta-analysis and meta-regression of randomized, controlled trials","volume":"77","author":"Bergmann","year":"2023","journal-title":"Clin Infect Dis."},{"issue":"6","key":"10.1016\/j.eimce.2024.07.001_bib0290","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S2213-2600(20)30080-1","article-title":"Immunomodulation by macrolides: therapeutic potential for critical care","volume":"8","author":"Reijnders","year":"2020","journal-title":"Lancet Respir Med."},{"issue":"12","key":"10.1016\/j.eimce.2024.07.001_bib0295","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"\u03b2-lactam monotherapy vs \u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med."},{"issue":"4","key":"10.1016\/j.eimce.2024.07.001_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106942","article-title":"Macrolides for better resolution of community-acquired pneumonia: A global meta-analysis of clinical outcomes with focus on microbial aetiology","volume":"62","author":"Kyprianou","year":"2023","journal-title":"Int J Antimicrob Agents."},{"issue":"23","key":"10.1016\/j.eimce.2024.07.001_bib0305","first-page":"00412","article-title":"Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial","volume":"S2213-2600","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Lancet Respir Med."},{"issue":"3","key":"10.1016\/j.eimce.2024.07.001_bib0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106905","article-title":"Respiratory fluoroquinolone monotherapy vs. beta-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Choi","year":"2023","journal-title":"Int J Antimicrob Agents."},{"key":"10.1016\/j.eimce.2024.07.001_bib0315","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2016-000152","article-title":"Serum levels of immunoglobulins and severity of community-acquired pneumonia","volume":"3","author":"de la Torre","year":"2016","journal-title":"BMJ Open Resp Res."},{"issue":"3","key":"10.1016\/j.eimce.2024.07.001_bib0320","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cid\/civ307","article-title":"Intravenous immunoglobulin and mortality in pneumonia patients with septic shock: an observational nationwide study","volume":"61","author":"Tagami","year":"2015","journal-title":"Clin Infect Dis."},{"issue":"4","key":"10.1016\/j.eimce.2024.07.001_bib0325","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00134-018-5143-7","article-title":"Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)","volume":"44","author":"Welte","year":"2018","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.eimce.2024.07.001_bib0330","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1186\/s13054-023-04719-9","article-title":"The immunomodulating activity of trimodulin (polyvalent IgM, IgA, IgG solution): a post hoc analysis of the phase II CIGMA trial","volume":"27","author":"Singer","year":"2023","journal-title":"Crit Care."}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X24001771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X24001771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T17:20:41Z","timestamp":1727976041000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X24001771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2529993X24001771"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2024.07.001","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How can we optimize the diagnostic and therapeutic approach to pneumonia? Expert opinion-based recommendations","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2024.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2024.06.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica.","name":"copyright","label":"Copyright"}]}}